Ullah, S.; Abid, R.; Haider, S.; Khuda, F.; Albadrani, G.M.; Abdulhakim, J.A.; Altyar, A.E.; Abdel-Daim, M.M.; Halimi, S.M.A.; Khalil, A.A.K.
Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19). Medicina 2022, 58, 1076.
https://doi.org/10.3390/medicina58081076
AMA Style
Ullah S, Abid R, Haider S, Khuda F, Albadrani GM, Abdulhakim JA, Altyar AE, Abdel-Daim MM, Halimi SMA, Khalil AAK.
Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19). Medicina. 2022; 58(8):1076.
https://doi.org/10.3390/medicina58081076
Chicago/Turabian Style
Ullah, Sami, Radhya Abid, Sana Haider, Fazli Khuda, Ghadeer M. Albadrani, Jawaher A. Abdulhakim, Ahmed E. Altyar, Mohamed M. Abdel-Daim, Syed Muhammad Ashhad Halimi, and Atif Ali Khan Khalil.
2022. "Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19)" Medicina 58, no. 8: 1076.
https://doi.org/10.3390/medicina58081076
APA Style
Ullah, S., Abid, R., Haider, S., Khuda, F., Albadrani, G. M., Abdulhakim, J. A., Altyar, A. E., Abdel-Daim, M. M., Halimi, S. M. A., & Khalil, A. A. K.
(2022). Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19). Medicina, 58(8), 1076.
https://doi.org/10.3390/medicina58081076